Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
B. Pippard (Newcastle upon Tyne, United Kingdom), M. Neal (Newcastle upon Tyne, United Kingdom), I. Forrest (Newcastle upon Tyne, United Kingdom), I. Sabroe (Sheffield, United Kingdom), R. Lawson (Sheffield, United Kingdom), A. Simpson (Newcastle upon Tyne, United Kingdom), J. Wild (Sheffield, United Kingdom), P. Thelwall (Newcastle upon Tyne, United Kingdom)
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Session: New imaging techniques applied to old problems
Session type: E-poster session
Number: 861
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Pippard (Newcastle upon Tyne, United Kingdom), M. Neal (Newcastle upon Tyne, United Kingdom), I. Forrest (Newcastle upon Tyne, United Kingdom), I. Sabroe (Sheffield, United Kingdom), R. Lawson (Sheffield, United Kingdom), A. Simpson (Newcastle upon Tyne, United Kingdom), J. Wild (Sheffield, United Kingdom), P. Thelwall (Newcastle upon Tyne, United Kingdom). Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI. 861
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Evaluation of bronchodilator responses in patients with advanced COPD Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001
How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Bronchodilator reversibility - differences between asthma and COPD Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Evaluation of vibration response imaging (VRI) in COPD and asthma patients before and after bronchodilators Source: Eur Respir J 2007; 30: Suppl. 51, 100s Year: 2007
Analysis of bronchodilator response in patients with controlled asthma Source: Eur Respir J 2004; 24: Suppl. 48, 223s Year: 2004
Perceived bronchodilator efficacy during severe asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Adhesion to inhaled treatment in patients with asthma and COPD Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Determinants of incorrect inhalation technique in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 69s Year: 2001
Restoring corticosteroid sensitivity in COPD and smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Obesity and the response to inhaled budesonide in patients with asthma Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
What influences the response to training of inhalation technique in patients with asthma and COPD? Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018